Appointment of Nominated Adviser /Corporate Broker

In brief · summary, not quotable

Creo Medical Group plc has appointed Shore Capital and Corporate Limited as its Nominated Adviser and Shore Capital Stockbrokers Limited as its sole Corporate Broker, effective immediately. This announcement is significant for the medical device company, which focuses on minimally invasive surgical endoscopy for pre-cancer and cancer patients, as it secures new advisory and brokerage relationships.

Full announcement

Select text to share a quote on X · sign in to keep highlights & notes in your CREO notes

Creo Medical Group plc (AIM: CREO), the medical device company focused on the emerging field of minimally invasive surgical endoscopy for pre-cancer and cancer patients, announces the appointment of Shore Capital and Corporate Limited as its Nominated Adviser and Shore Capital Stockbrokers Limited as its sole Corporate Broker with immediate effect.

Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.